Overview

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis

Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effectiveness and safety of infliximab (Remicade) in patients with plaque-type psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
Centocor, Inc.
Treatments:
Infliximab